Takeda submits new drug application in japan for lanadelumab as a preventive treatment for hereditary angioedema attacks

Osaka, japan--(business wire)--takeda submits new drug application in japan for lanadelumab as a preventive treatment for hereditary angioedema attacks

TAK Ratings Summary

TAK Quant Ranking